Ardea Announces Data on MEK Inhibitor BAY 86-9766 (RDEA119) to be Presented at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Th... (kinase (MEK) for the treatment of cancer...)

HOME >> MEDICINE >> TECHNOLOGY

Ardea Announces Data on MEK Inhibitor BAY 86-9766 (RDEA119) to be Presented at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Date:11/11/2010

kinase (MEK) for the treatment of cancer being developed under a global license agreement with Bayer HealthCare AG. BAY 86-9766 has been evaluated in advanced cancer patients with different tumor types as a single agent in a Phase 1 study and is currently being evaluated in combination with sorafenib (Nexavar®; Bayer HealthCare, Onyx Pharmaceuticals) in a Phase 1/2 study. Our two product candidates for the treatment of HIV, RDEA806 and RDEA427, are non-nucleoside reverse transcriptase inhibitors (NNRTIs), which have successfully completed a Phase 2a study in HIV patients and a human micro-dose pharmacokinetic study in healthy volunteers, respectively.

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding our plans and goals, the expected properties and benefits of RDEA594, BAY 86-9766 (RDEA119), RDEA806, RDEA427 and our other compounds and the timing and results of our preclinical, clinical and other studies. Risks that contribute to the uncertain nature of the forward-looking statements include risks related to the outcome of preclinical and clinical studies, risks related to regulatory approvals, delays in commencement of preclinical and clinical studies, costs associated with our drug discovery and development programs, and risks related to the outcome of our business development activities, including collaboration or license agreements. These and other risks and uncertainties are described more fully in our most recently filed SEC documents, including our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q, under
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Ardea Biosciences to Present at Four Upcoming Investor Conferences
2. Ardea Biosciences Reports Recent Accomplishments; Provides 2010 Outlook; Announces Fourth Quarter and Full-Year 2009 Financial Results and 2010 Financial Guidance
3. Ardea Biosciences to Present at Two Upcoming Investor Conferences
4. Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results
5. Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting
6. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at American College of Gastroenterology Annual Scientific Meeting
7. Ardea Biosciences Advances Lead Product Candidate for the Treatment of Gout, RDEA594, Into Phase 1 Clinical Trial
8. Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference
9. Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
10. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
11. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis

Post Your Comments:

(Date:5/24/2013)... , May 24, 2013 Heska Corporation (NASDAQ: HSKA, ... and specialty products, announced today that Dr. Robert ... and Jason Napolitano , executive vice president ... Marcum MicroCap Conference, which is being held May 30, 2013 ... Grand Hyatt Hotel. The Company,s presentation is ...

(Date:5/24/2013)... In accordance with Rule 17.1 and Rule 2.9 ... United States Exchange Act, Echo Pharma Acquisition Limited ("Royalty Pharma") ... (NYSE: ELN). Background On 2 May ... for the entire of the issued and to be issued ... On 20 May 2013, Royalty Pharma announced ...

(Date:5/24/2013)... England and BOSTON , ... GPCR drug discovery and development company, is pleased to announce that ... a Consultant to augment the Company,s business development capabilities in ... Usui has more than 15 years of experience in business development, ... at Perlegen Sciences, Inc., Roche Pharma ( Japan ), ...

[0] Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference [0] Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements [0] Heptares Augments Business Development Capabilities in Japan and Other Asian Territories

... PRINCETON, N.J., Sept. 13, 2011 Kremers Urban Pharmaceuticals ... a settlement dismissing all pending litigation arising from its ... release methylphenidate hydrochloride product, for which Concerta® is the ... with FDA. The settlement includes a ...

... BALTIMORE, Sept. 13, 2011 Champions Oncology, Inc. formerly ... Fiscal Year 2012 First Quarter Financial ... 2012 were $1.63 million compared to $1.60 million in ... for the first quarter of fiscal 2012 were $3.85 ...

Cached Medicine Technology:Champions Oncology Reports Fiscal 2012 First Quarter Financial Results 2 Champions Oncology Reports Fiscal 2012 First Quarter Financial Results 3 Champions Oncology Reports Fiscal 2012 First Quarter Financial Results 4 Champions Oncology Reports Fiscal 2012 First Quarter Financial Results 5

Kremers Urban Pharmaceuticals Inc. Settles Concerta® Patent Litigation Champions Oncology Reports Fiscal 2012 First Quarter Financial Results

(Date:5/25/2013)... (PRWEB) May 25, 2013 On May 20, ... people do not wish to discuss or plan for their ... FuneralFinancials.com released a Must-Do List to help ... Funeral Financials recommends, “Creating a personal fact sheet.” , While ... organize financial information and personal data. It may include ...

(Date:5/25/2013)... 25, 2013 The latest report ... irritable bowel syndrome (IBS) to bloating, constipation, diarrhea ... most long-lasting, embarrassing, frustrating and difficult health issues ... digestive health have provided a cure for ... factors contributing to digestive health issues, a healthy ...

(Date:5/25/2013)... On May 25, Voices Against Brain ... advocacy, comments on a new study by the Max ... atmospheric plasma into brain cancer treatment may help when ... Science Daily article, physicists from the Max ... demonstrated the “synergistic effect of cold atmospheric plasma -- ...

(Date:5/25/2013)... Many orthodontists have thought about moving ... that cloud is. Most people would naturally assume ... provide their cloud service and support would own and ... they're selling, they'd be wrong. Cloud providers lease ... redundant facility that houses servers and related equipment to ...

(Date:5/25/2013)... 2013 According to world-renowned scholars, Queen ... powerful women that ever lived. Cleopatra’s legendary beauty moved ... the most powerful men in her time. Cleopatra was ... keep her skin glowing and fresh, from her legendary ... maringa oil and cyprus grass. , Cleopatra was said ...

Breaking Medicine News(10 mins):Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2 Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2 Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2 Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3

[0] FuneralFinancials.com Releases Last Wishes Must-Do List [0] Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org [0] Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells [0] Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other [0] The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician

... Canadian study found new arrivals tended to be healthy , ... and the United States may be less likely to suffer ... new study has found. , University of Toronto researchers identified ... compared them with more than 3.2 million people who,d lived ...

... ... joined by the NAACP, American Diabetes Association and Greater Philadelphia Health Action, Inc and ... ... families are expected to attend the “Outreach Day” event on Thursday, February 4, 2010, ...

... , CINCINNATI , ... has been marked as the winningest in franchise history, with a first ... DREW BREES ( PURDUE ) consistent and dependable ... today. The New Orleans Saints offensive line was the first to be ...

... KNOXVILLE, Tenn. , Feb. 3 TeamHealth Holdings, Inc. ... of outsourced healthcare professional staffing and administrative services to hospitals and ... that the Company will release its fourth quarter and full fiscal ... 2010 , to be followed by a conference call on ...

... , WASHINGTON , Feb. 3 ... treat the victims of the devastating earthquake, the American Red Cross is ... the request of the Pan American Health Organization (PAHO). , (Logo: ... the shipment of 350 units of blood to Haiti – ...

... , , ... alerting the public about the following products: , (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ... capsules (120-count refill kit) sold over the Internet contains a different ... have needles that detach from the syringe and could remain in ...

Cached Medicine News:Health News:Immigrants at Lower Stroke Risk Than Long-Term Residents? 2 Health News:More Than 250 Philadelphia Diabetics Expected to Attend "Outreach Day" 2 Health News:New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R) 2 Health News:New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R) 3 Health News:New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R) 4 Health News:New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R) 5 Health News:TeamHealth Holdings, Inc. Announces Fourth Quarter and Full Fiscal 2009 Earnings Release Date and Conference Call 2 Health News:TeamHealth Holdings, Inc. Announces Fourth Quarter and Full Fiscal 2009 Earnings Release Date and Conference Call 3 Health News:American Red Cross and Other U.S. Blood Centers Send Blood to Haiti 2 Health News:American Red Cross and Other U.S. Blood Centers Send Blood to Haiti 3 Health News:FDA Consumer Health Information - FDA's MedWatch Safety Alerts: January 2010 2

Immigrants at Lower Stroke Risk Than Long-Term Residents?More Than 250 Philadelphia Diabetics Expected to Attend "Outreach Day"New Orleans Saints Offensive Line Honored with First Madden Most Valuable Protectors Award Presented by Prilosec OTC(R)TeamHealth Holdings, Inc. Announces Fourth Quarter and Full Fiscal 2009 Earnings Release Date and Conference Call American Red Cross and Other U.S. Blood Centers Send Blood to Haiti FDA Consumer Health Information - FDA's MedWatch Safety Alerts: January 2010

Lumbar External Drainage System (LED) with Touhy needle is indicated for temporary access to the Lumbar Subarachnoid region as a means of draining cerebral spinal fluid (CSF) in order to reduce incre...

Monitorr ICP external CSF drainage and monitoring system with patient line one way valve....

Skull Traction Tongs for cervical vertebra extension, adjustable pins, eliminates need for preliminary drilling, large pattern, complete with wrench...

Cushing Flat Drill, only Component Parts and Accessories for HUDSON Cranial Drill. 14 mm...

Medicine Products:

Lumbar External Drainage System (LED)Monitorr ICP External CSF Drainage and Monitoring System Skull Traction Tongs Cushing Flat Drill